PURIFICATION OF THE 5-HYDROXYTRYPTAMINE 5-HT3 RECEPTOR FROM NCB20 CELLS

被引:0
|
作者
MCKERNAN, RM [1 ]
GILLARD, NP [1 ]
QUIRK, K [1 ]
KNEEN, CO [1 ]
STEVENSON, GI [1 ]
SWAIN, CJ [1 ]
RAGAN, CI [1 ]
机构
[1] MERCK SHARP & DOHME LTD,NEUROSCI RES CTR,DEPT CHEM,HARLOW CM20 2QR,ESSEX,ENGLAND
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A 5-hydroxytryptamine 5-HT3 receptor binding site has been purified from deoxycholate-solubilized NCB20 cell membranes. Purification (1,700-fold) was achieved in one step by affinity chromatography with L-685,603 immobilized on agarose. The 5-HT3 selective antagonist [3H]Q ICS 205-930 labeled a single population of receptors in the affinity-purified preparation with a Bmax of 3.1 ± 0.9 nmol/mg protein and Kd of 0.40 ± 0.05 nM (mean ± S.E., n = 3). The rank order of potency for a series of competing compounds confirmed that [3H]Q ICS 205,930 was labeling a 5-HT3 receptor in the purified preparation, and the inhibition constants for all antagonists were unchanged after purification. The purified 5-HT3 binding site eluted from a Sepharose 6B gel filtration column in a similar manner to the crude solubilized preparation (Stokes radius of 4.9 nm, apparent molecular size 250,000). Polyacrylamide gel electrophoresis of the affinity-purified receptor showed two broad bands by silver staining, migrating with apparent molecular masses of 54,000 and 38,000. Gel filtration of the affinity purified material yielded a single peak labeled by [3H]Q ICS 205-930 with an apparent molecular size of 250,000, which was also composed of two bands of 54,000 and 38,000, consistent with these being the constituents of the 5-HT3 receptor.
引用
收藏
页码:13572 / 13577
页数:6
相关论文
共 50 条
  • [21] 5-hydroxytryptamine (5-HT) receptor ligands
    Kitson, Sean L.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (25) : 2621 - 2637
  • [22] Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT3 receptor currents in NCB-20 cells
    Park, Yong Soo
    Sung, Ki-Wug
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2019, 23 (06): : 509 - 517
  • [23] 5-HT-INDUCED CURRENTS IN NCB-20 NEURO-BLASTOMA HYBRID-CELLS AND THEIR BLOCKADE BY A 5-HT3 RECEPTOR ANTAGONIST
    HALES, TG
    LAMBERT, JJ
    PETERS, JA
    BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 : P393 - P393
  • [24] THE ACTION OF SDZ 205,557 AT 5-HYDROXYTRYPTAMINE (5-HT3 AND 5-HT4) RECEPTORS
    EGLEN, RM
    ALVAREZ, R
    JOHNSON, LG
    LEUNG, E
    WONG, EHF
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) : 376 - 382
  • [25] Phosphorylation of the 5-Hydroxytryptamine3 (5-HT3) receptor expressed in HEK293 cells
    Lankiewicz, S
    Hüser, MB
    Heumann, R
    Hatt, H
    Gisselmann, G
    RECEPTORS & CHANNELS, 2000, 7 (01): : 9 - 15
  • [26] Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors
    Jin, JG
    Foxx-Orenstein, AE
    Grider, JR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (01): : 93 - 97
  • [27] 5-hydroxytryptamine 1A (5-HT1A) but not 5-HT3 receptor is involved in mediating the nucleus submedius 5-HT-evoked antinociception in the rat
    Xiao, DQ
    Zhu, JX
    Tang, JS
    Jia, H
    BRAIN RESEARCH, 2005, 1046 (1-2) : 38 - 44
  • [28] Role of 5-hydroxytryptamine(3) (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy
    Karim, F
    Roerig, SC
    Saphier, D
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (05) : 685 - 692
  • [29] ETHANOL POTENTIATION OF 5-HT3 RECEPTOR-MEDIATED ION CURRENT IN NCB-20 NEUROBLASTOMA-CELLS
    LOVINGER, DM
    NEUROSCIENCE LETTERS, 1991, 122 (01) : 57 - 60
  • [30] CHEMICAL MODULATION OF 5-HT3 AND 5-HT4 RECEPTORS AFFECTS THE RELEASE OF 5-HYDROXYTRYPTAMINE FROM THE FERRET AND RAT INTESTINE
    MINAMI, M
    TAMAKAI, H
    OGAWA, T
    ENDO, T
    HAMAUE, N
    HIRAFUJI, M
    YOSHIOKA, M
    BLOWER, PR
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1995, 89 (02) : 131 - 142